Macrophage-derived CXCL9 and CXCL11 recruit CD8 T cells in skin and provide long-term disease control in mogamulizumab-treated CTCL patients

Authors :: Hélène Moins-Teisserenc
Jean-David Bouaziz
Marie Roelens
G. Dobos
Samia Mourah
Aurélie Sadoux
Delphine Darbord
Marie Boisson
Martine Bagot
Hélène Le Buanec
Anne Marie-Cardine
Maxime Battistella
Charles Cassius
Adèle de Masson
Caroline Ram-Wolff
Baptiste Louveau
Pierre de la Grange
Fanélie Jouenne
Source :: European Journal of Cancer. 156:S19-S20
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Cancer Research
Oncology
business.industry
Immunology
Mogamulizumab
medicine
CXCL9
Cytotoxic T cell
Macrophage
CXCL11
business
Disease control
medicine.drug

Full Text Access

Tools